Lopa Dalmia, DPM
Podiatry · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 23
- 5 carriers
- Office
- 1
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
23 plans · 5 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Dalmia’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
23 of 23 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$13,574
Medicare paid this office $13,574 for 63 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 31 | $4,605 | $55 |
| Return visit (30+ min) | 16 | $1,678 | $84 |
| Removal of fingernails or toenails, 6 or more nails | 25 | $1,154 | $20 |
| Removal of noncancer thickened skin growth, 2-4 growths | 13 | $400 | $18 |
Procedures Medicare counted
| Removal of nail tissue | 106 | More than 70% of doctors who do this |
| Removal of tissue | 15 | More than 66% of doctors who do this |
| Removal or shaving of skin growth | 45 | More than 78% of doctors who do this |
Who their Medicare patients are
63 Original Medicare patients in 2024. Average age 68 · Under 65 35% · Women 43% · Health risk score 2.85. Sicker patients than 9 in 10 peers; the typical podiatry clinician is at 1.55.
Conditions among them: High blood pressure 75% · Diabetes 73% · Chronic kidney disease 46% · Heart failure 33% · Depression 32% · Coronary heart disease 25%.
The office billed $156,807, Medicare allowed $17,835 and paid $13,574; for 252 services of 25 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 63 | 252 | 68 | 2.85 | $156,807 | $13,574 |
| 2023 | 90 | 287 | 69 | 4.09 | $180,359 | $15,962 |
| 2022 | 132 | 339 | 70 | 3.06 | $213,297 | $18,360 |
| 2021 | 109 | 216 | 71 | 2.98 | $129,789 | $12,519 |
| 2020 | 93 | 264 | 71 | 2.57 | $76,995 | $18,518 |
| 2019 | 183 | 632 | 73 | 1.91 | $158,820 | $45,837 |
| 2018 | 81 | 300 | 72 | 1.70 | $66,835 | $18,672 |
| 2017 | 200 | 416 | 73 | 2.14 | $78,885 | $20,287 |
| 2016 | 380 | 1,020 | 71 | 1.61 | $170,510 | $56,766 |
| 2015 | 379 | 833 | 72 | 1.72 | $135,413 | $48,100 |
| 2014 | 437 | 1,457 | 70 | 1.52 | $211,080 | $87,448 |
| 2013 | 271 | 1,064 | 70 | 1.72 | $154,795 | $64,229 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Short return visit (20+ min) | 38 | $3,784 | $56 |
| Return visit (30+ min) | 19 | $1,837 | $80 |
| Removal of fingernails or toenails, 6 or more nails | 42 | $1,122 | $18 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 14 | $1,096 | $73 |
| Removal of skin and tissue, 20.0 sq cm or less | 14 | $1,079 | $51 |
| Removal of noncancer thickened skin growth, 2-4 growths | 16 | $380 | $17 |
| Short return visit | 11 | $359 | $33 |
| Removal of noncancer thickened skin growth, 1 growth | 13 | $251 | $13 |
2022: 6 services
| Short return visit (20+ min) | 31 | $3,411 | $55 |
| Return visit (30+ min) | 42 | $3,292 | $72 |
| Removal of skin and tissue, 20.0 sq cm or less | 19 | $2,247 | $55 |
| Removal of fingernails or toenails, 6 or more nails | 64 | $1,741 | $20 |
| Removal of noncancer thickened skin growth, 2-4 growths | 16 | $319 | $19 |
| Removal of noncancer thickened skin growth, 1 growth | 17 | $249 | $13 |
2021: 5 services
| Short return visit (20+ min) | 59 | $4,325 | $57 |
| Return visit (30+ min) | 14 | $1,238 | $83 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $845 | $53 |
| Telephone medical discussion with physician, 11-20 minutes | 17 | $839 | $38 |
| Removal of fingernails or toenails, 6 or more nails | 27 | $541 | $19 |
2020: 4 services
| Short return visit (20+ min) | 50 | $3,222 | $49 |
| New patient visit (30+ min) | 17 | $859 | $51 |
| Removal of fingernails or toenails, 6 or more nails | 25 | $743 | $28 |
| X-ray of foot, minimum of 3 views | 12 | $245 | $16 |
2019: 9 services
| Short return visit (20+ min) | 100 | $10,455 | $57 |
| New patient visit (30+ min) | 92 | $7,282 | $79 |
| Removal of skin and tissue, 20.0 sq cm or less | 18 | $4,018 | $98 |
| Removal of fingernails or toenails, 6 or more nails | 51 | $2,362 | $37 |
| New patient visit (45+ min) | 15 | $2,037 | $136 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 12 | $1,990 | $166 |
| X-ray of foot, minimum of 3 views | 41 | $1,380 | $25 |
| Removal of noncancer thickened skin growth, 1 growth | 23 | $1,287 | $46 |
| Removal of noncancer thickened skin growth, 2-4 growths | 13 | $653 | $47 |
2018: 5 services
| Short return visit (20+ min) | 46 | $4,995 | $56 |
| New patient visit (30+ min) | 43 | $3,390 | $79 |
| Removal of fingernails or toenails, 6 or more nails | 26 | $1,173 | $36 |
| Removal of noncancer thickened skin growth, 1 growth | 17 | $1,023 | $37 |
| X-ray of foot, minimum of 3 views | 13 | $453 | $24 |
2017: 7 services
| Removal of skin and tissue, 20.0 sq cm or less | 17 | $4,791 | $92 |
| Removal of fingernails or toenails, 6 or more nails | 94 | $4,150 | $29 |
| Return visit (30+ min) | 45 | $3,952 | $71 |
| Removal of noncancer thickened skin growth, 1 growth | 30 | $1,502 | $32 |
| Short return visit (20+ min) | 13 | $842 | $53 |
| Removal of noncancer thickened skin growth, 2-4 growths | 16 | $761 | $35 |
| New patient visit (15+ min) | 12 | $616 | $51 |
2016: 14 services
| Removal of skin and tissue, 20.0 sq cm or less | 37 | $11,679 | $91 |
| Return visit (30+ min) | 111 | $9,994 | $76 |
| Removal of fingernails or toenails, 6 or more nails | 119 | $9,413 | $32 |
| New patient visit (30+ min) | 41 | $3,381 | $82 |
| New patient visit (15+ min) | 52 | $2,853 | $55 |
| Removal of noncancer thickened skin growth, 1 growth | 44 | $2,759 | $35 |
| Permanent removal fingernail or toenail | 13 | $2,522 | $140 |
| Removal of noncancer thickened skin growth, 2-4 growths | 17 | $1,623 | $45 |
| Short return visit (20+ min) | 29 | $1,587 | $53 |
| Long return visit (40+ min) | 11 | $1,488 | $106 |
| Initial physician evaluation and management of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) which must include: (1) the diagnosis of lops, (2) a patient history, (3) a physical examination that cons | 15 | $723 | $48 |
| Routine foot care by a physician of a diabetic patient with diabetic sensory neuropathy resulting in a loss of protective sensation (lops) to include, the local care of superficial wounds (i.e. superficial to muscle and fascia) and at least the following i | 11 | $480 | $44 |
| Administration of influenza virus vaccine | 15 | $382 | $25 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 15 | $280 | $19 |
2015: 9 services
| Return visit (30+ min) | 79 | $7,478 | $80 |
| Removal of fingernails or toenails, 6 or more nails | 143 | $7,292 | $32 |
| Removal of skin and tissue, 20.0 sq cm or less | 26 | $6,354 | $91 |
| New patient visit (30+ min) | 63 | $5,120 | $81 |
| Short return visit (20+ min) | 57 | $3,614 | $52 |
| New patient visit (15+ min) | 57 | $2,982 | $52 |
| Removal of noncancer thickened skin growth, 1 growth | 38 | $1,979 | $35 |
| Removal of fingernails or toenails, 1-5 nails | 13 | $454 | $25 |
| Removal of fingernails or toenails, 6 or more nails | 13 | $378 | $20 |
2014: 19 services
| Return visit (30+ min) | 119 | $15,959 | $85 |
| Removal of fingernails or toenails, 6 or more nails | 176 | $12,175 | $34 |
| New patient visit (30+ min) | 123 | $10,376 | $84 |
| Short return visit (20+ min) | 102 | $8,190 | $58 |
| Removal of skin and tissue, 20.0 sq cm or less | 33 | $7,269 | $94 |
| New patient visit (15+ min) | 85 | $4,734 | $56 |
| Permanent removal fingernail or toenail | 19 | $4,260 | $152 |
| Long return visit (40+ min) | 20 | $3,760 | $118 |
| New patient visit (45+ min) | 15 | $2,015 | $134 |
| Removal of noncancer thickened skin growth, 1 growth | 42 | $1,954 | $36 |
| Removal of noncancer thickened skin growth, 2-4 growths | 14 | $1,393 | $44 |
| Application of short leg cast | 12 | $1,225 | $51 |
| Removal of skin and tissue, 20.0 sq cm or less | 11 | $958 | $46 |
| Removal of fingernails or toenails, 6 or more nails | 22 | $707 | $20 |
| Administration of influenza virus vaccine | 12 | $306 | $25 |
| Removal of noncancer thickened skin growth, 1 growth | 15 | $296 | $11 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 11 | $194 | $18 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 13 | $188 | $8 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 16 | $115 | None |
2013: 14 services
| Return visit (30+ min) | 90 | $11,816 | $84 |
| Removal of fingernails or toenails, 6 or more nails | 111 | $8,942 | $35 |
| Short return visit (20+ min) | 77 | $8,550 | $56 |
| New patient visit (30+ min) | 63 | $5,480 | $87 |
| New patient visit (15+ min) | 43 | $2,511 | $58 |
| Removal of noncancer thickened skin growth, 1 growth | 35 | $2,207 | $39 |
| Removal of skin and tissue, 20.0 sq cm or less | 13 | $2,085 | $95 |
| New patient visit (45+ min) | 12 | $1,599 | $133 |
| Removal of skin and tissue, 20.0 sq cm or less | 16 | $1,536 | $50 |
| Removal of noncancer thickened skin growth, 2-4 growths | 11 | $1,191 | $44 |
| Return visit (30+ min) | 14 | $1,047 | $58 |
| Removal of fingernails or toenails, 6 or more nails | 14 | $526 | $19 |
| Removal of noncancer thickened skin growth, 1 growth | 11 | $294 | $12 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 12 | $89 | None |
Medicaid work
$6,093 in 2024
Medicaid paid $6,093 for 1,256 billed services this clinician did in 2024, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 353 | $3,197 |
| Return visit (30+ min) | 112 | $1,004 |
| New patient visit (45+ min) | 15 | $817 |
| Debridement of nail(s) by any method(s); 6 or more | 250 | $779 |
| Service | 252 | $166 |
| New patient visit (30+ min) | 12 | $129 |
| Pain severity quantified; no pain present (COA) (ONC) | 15 | $0 |
| Medication list documented in medical record (COA) | 235 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 12 | $0 |
| 2024 | 1,256 | 9 | 42 | $6,093 |
| 2023 | 1,385 | 8 | 61 | $6,149 |
| 2022 | 973 | 6 | 45 | $5,784 |
| 2021 | 631 | 5 | 66 | $3,330 |
| 2020 | 111 | 1 | 37 | $2,537 |
| 2019 | 355 | 2 | 24 | $16,216 |
| 2018 | 159 | 2 | 20 | $8,369 |
See the largest Medicaid services in earlier years
2023
| Short return visit (20+ min) | 461 | $2,208 |
| Return visit (30+ min) | 194 | $1,185 |
| Debridement of nail(s) by any method(s); 6 or more | 257 | $877 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 104 | $765 |
| Service | 244 | $437 |
| Hospital outpatient clinic visit for assessment and management of a patient | 16 | $303 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 59 | $194 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single lesion | 50 | $181 |
2022
| Short return visit (20+ min) | 443 | $2,636 |
| Return visit (30+ min) | 190 | $1,442 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 90 | $1,105 |
| Debridement of nail(s) by any method(s); 6 or more | 225 | $554 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); 2 to 4 lesions | 12 | $31 |
| Paring or cutting of benign hyperkeratotic lesion (eg, corn or callus); single lesion | 13 | $15 |
2021
| Short return visit (20+ min) | 557 | $3,283 |
| Debridement of nail(s) by any method(s); 6 or more | 26 | $47 |
| Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | 15 | $0 |
| REMOVAL OF NAIL BED | 12 | $0 |
| Return visit (30+ min) | 21 | $0 |
2020
| Short return visit (20+ min) | 111 | $2,537 |
2019
| New patient visit (30+ min) | 138 | $8,393 |
| Short return visit (20+ min) | 217 | $7,823 |
2018
| New patient visit (30+ min) | 65 | $4,451 |
| Short return visit (20+ min) | 94 | $3,918 |
Drugs they prescribed that Part D paid
$2,326
Pharmacies billed $2,326 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
117 generic and 0 brand-name prescriptions · $2,326 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ammonium Lactate | 38 | $1,548 | $22 |
| Clotrimazole | 11 | $478 | $27 |
Year by year
| 2024 | 117 | 49 | None | 0% | $2,326 |
| 2023 | 65 | 40 | None | 0% | $1,405 |
| 2022 | 39 | 18 | None | None | $1,062 |
| 2021 | 32 | 17 | 0% (0) | None | $1,038 |
| 2020 | 44 | 27 | None | 27% | $1,217 |
| 2019 | 69 | 36 | None | None | $1,244 |
| 2018 | 23 | 17 | None | None | $231 |
| 2017 | 18 | 11 | None | None | $3,053 |
| 2016 | 53 | 31 | None | 26% | $6,624 |
| 2015 | 21 | 11 | None | None | $283 |
| 2014 | 57 | 39 | None | None | $1,205 |
| 2013 | 56 | 29 | None | None | $1,972 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Ammonium Lactate | 47 | $998 | $21 |
2022: 1 drug
| Mupirocin | 13 | $357 | $27 |
2014: 1 drug
| Silver Sulfadiazine | 14 | $168 | $12 |
Money from drug and device companies
$23 in 2022
| 2022 | 1 | 1 | None | $23 |
| 2021 | 1 | 1 | None | $25 |
| 2020 | 1 | 2 | None | $34 |
| 2019 | 4 | 4 | None | $284 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Smith+Nephew | Stravix | $23 | 1 payment
|
See the published payment
| Smith+Nephew | Meals · 2022-12-22 | Stravix | $23 |
See earlier years (2021, 2020, 2019)
2021: $25
| AbbVie | Dalvance | $25 | 1 payment
|
2020: $34
| Smith+Nephew | Grafix Pl | $34 | 2 payments
|
2019: $284
| Organogenesis | Apligraf | $117 | 1 payment
|
| Wright Medical Technology | Augment | $78 | 1 payment
|
| Stryker | Iconix | $71 | 1 payment
|
| Horizon Therapeutics plc | Krystexxa | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1386884237
- Licence
- OR DP183642
- Trained
- Temple University School of Medicine, 2006
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 213ES0103X (213ES0103X)
- Mailing address
- 12400 Nw Cornell Rd Ste 201, Portland, OR, 97229
- NPI first listed
- 2009-03-04
- NPI last updated
- 2017-11-06
This is when the NPI record was last certified, not a medical board exam.